Unichem Laboratories profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
9.8%9.8%5.7%−2.9%−8.0%
6.9%6.9%4.1%−2.2%−6.2%
2.2%2.2%5.6%−0.5%−6.2%
3.2%1.8%4.5%−0.5%−6.2%
Margins
9.9%8.4%12.6%5.9%−3.4%
2.7%2.7%6.7%−0.8%−11.8%
—−89.4%37.7%40.3%—
15.2%13.3%7.3%−3.6%−13.1%
13.2%11.5%6.5%−4.1%−15.1%
—11.5%6.5%−4.1%—
−5.4%−5.4%−6.8%−0.3%−9.6%
Additional
13.0%13.5%11.0%−14.3%−14.7%
—0.0%0.2%−0.3%−14.0%
9.8%9.8%5.7%−2.9%−9.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

UNICHEMLAB₹488.80

Unichem Laboratories Limited

· Pharma & Health
₹ CrorePeersGUFICBIORPGLIFEGUJTHEMSMSPHARMAORCHPHARMAINDSWFTLABSOLARAFDCMcap ₹3,441 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity-8.00-2.945.719.789.78
Return on Assets-6.21-2.224.086.926.92
Return on Capital Employed-6.23-0.525.572.182.18
Return on Invested Capital-6.24-0.534.471.763.16
Margins
EBITDA Margin-3.395.8812.558.369.90
Operating Margin-11.84-0.766.652.682.68
Incremental Operating Margin—40.3537.75-89.40—
Pretax Margin-13.13-3.627.3213.2815.18
Net Income Margin-15.06-4.136.5111.4813.21
Net Income to Common Margin—-4.136.5111.48—
FCF Margin-9.64-0.34-6.84-5.42-5.42
Additional
Effective Tax Rate-14.67-14.2811.0413.5213.02
Dvd Payout Ratio-13.97-0.300.250.00—
Sustainable Growth Rate-9.12-2.955.709.789.78
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.